AMPK, SIRT1, and the NF-κB axis have important roles in renal damage and oxidative stress [58,59], so we orally administered GKA4 to inhibit cisplatin-induced AKI via the AMPK/SIRT1/NF-κB signaling progress. The gene discussed is SIRT1; the disease is acute kidney injury.